Literature DB >> 7887411

An intragenic deletion of the P gene is the common mutation causing tyrosinase-positive oculocutaneous albinism in southern African Negroids.

G Stevens1, J van Beukering, T Jenkins, M Ramsay.   

Abstract

Tyrosinase-positive oculocutaneous albinism (OCA2), an autosomal recessive disorder of the melanin biosynthetic pathway, is the most common recessive disorder occurring in southern African Bantu-speaking Negroids, with an overall prevalence of 1/3,900. The OCA2 gene, P, has been mapped to chromosome 15q11-q13, and recently alterations in the P gene have been identified in OCA2 individuals. An intragenic deletion has been described and proposed to be of African origin because of its occurrence in four unrelated African American OCA2 individuals and in two individuals, one from Zaire and the other from Cameroon. This study shows that the intragenic deletion is a common cause of OCA2 in southern African Negroids (114/146 [.78]; OCA2 chromosomes) and is associated with one common haplotype (43/55 [.78]; OCA2 chromosomes), confirming the African origin of this allele. On the basis of haplotype data, it would appear that at least seven additional, less frequent OCA2 mutations occur in this population.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7887411      PMCID: PMC1801183     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  21 in total

1.  The tyrosinase-positive oculocutaneous albinism locus maps to chromosome 15q11.2-q12.

Authors:  M Ramsay; M A Colman; G Stevens; E Zwane; J Kromberg; M Farrall; T Jenkins
Journal:  Am J Hum Genet       Date:  1992-10       Impact factor: 11.025

2.  Isolation and sequence of a cDNA clone for human tyrosinase that maps at the mouse c-albino locus.

Authors:  B S Kwon; A K Haq; S H Pomerantz; R Halaban
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

3.  A simple salting out procedure for extracting DNA from human nucleated cells.

Authors:  S A Miller; D D Dykes; H F Polesky
Journal:  Nucleic Acids Res       Date:  1988-02-11       Impact factor: 16.971

4.  The tyrosinase-positive oculocutaneous albinism gene shows locus homogeneity on chromosome 15q11-q13 and evidence of multiple mutations in southern African negroids.

Authors:  M A Kedda; G Stevens; P Manga; C Viljoen; T Jenkins; M Ramsay
Journal:  Am J Hum Genet       Date:  1994-06       Impact factor: 11.025

5.  Prevalence of albinism in the South African negro.

Authors:  J G Kromberg; T Jenkins
Journal:  S Afr Med J       Date:  1982-03-13

6.  Direct molecular identification of the mouse pink-eyed unstable mutation by genome scanning.

Authors:  M H Brilliant; Y Gondo; E M Eicher
Journal:  Science       Date:  1991-04-26       Impact factor: 47.728

7.  Albinism in Nigeria. A clinical and social study.

Authors:  A N Okoro
Journal:  Br J Dermatol       Date:  1975-05       Impact factor: 9.302

8.  Mutations of the P gene in oculocutaneous albinism, ocular albinism, and Prader-Willi syndrome plus albinism.

Authors:  S T Lee; R D Nicholls; S Bundey; R Laxova; M Musarella; R A Spritz
Journal:  N Engl J Med       Date:  1994-02-24       Impact factor: 91.245

9.  African origin of an intragenic deletion of the human P gene in tyrosinase positive oculocutaneous albinism.

Authors:  D Durham-Pierre; J M Gardner; Y Nakatsu; R A King; U Francke; A Ching; R Aquaron; V del Marmol; M H Brilliant
Journal:  Nat Genet       Date:  1994-06       Impact factor: 38.330

10.  Human tyrosinase gene, mapped to chromosome 11 (q14----q21), defines second region of homology with mouse chromosome 7.

Authors:  D E Barton; B S Kwon; U Francke
Journal:  Genomics       Date:  1988-07       Impact factor: 5.736

View more
  18 in total

1.  Oculocutaneous albinism in an isolated Tonga community in Zimbabwe.

Authors:  P M Lund; N Puri; D Durham-Pierre; R A King; M H Brilliant
Journal:  J Med Genet       Date:  1997-09       Impact factor: 6.318

2.  Rufous oculocutaneous albinism in southern African Blacks is caused by mutations in the TYRP1 gene.

Authors:  P Manga; J G Kromberg; N F Box; R A Sturm; T Jenkins; M Ramsay
Journal:  Am J Hum Genet       Date:  1997-11       Impact factor: 11.025

3.  Oculocutaneous albinism type 2 (OCA2) with homozygous 2.7-kb deletion of the P gene and sickle cell disease in a Cameroonian family. Identification of a common TAG haplotype in the mutated P gene.

Authors:  Robert Aquaron; Nadem Soufir; Jean-Louis Bergé-Lefranc; Catherine Badens; Frederic Austerlitz; Bernard Grandchamp
Journal:  J Hum Genet       Date:  2007-09-01       Impact factor: 3.172

4.  Genetic testing for oculocutaneous albinism type 1 and 2 and Hermansky-Pudlak syndrome type 1 and 3 mutations in Puerto Rico.

Authors:  Pedro J Santiago Borrero; Yolanda Rodríguez-Pérez; Jessicca Y Renta; Natalio J Izquierdo; Laura Del Fierro; Daniel Muñoz; Norma López Molina; Sonia Ramírez; Glorivee Pagán-Mercado; Idith Ortíz; Enid Rivera-Caragol; Richard A Spritz; Carmen L Cadilla
Journal:  J Invest Dermatol       Date:  2006-01       Impact factor: 8.551

5.  Distribution of oculocutaneous albinism in Zimbabwe.

Authors:  P M Lund
Journal:  J Med Genet       Date:  1996-08       Impact factor: 6.318

6.  Hypopigmentation in the Prader-Willi syndrome correlates with P gene deletion but not with haplotype of the hemizygous P allele.

Authors:  R A Spritz; T Bailin; R D Nicholls; S T Lee; S K Park; M J Mascari; M G Butler
Journal:  Am J Med Genet       Date:  1997-07-11

7.  Molecular and clinical characterization of albinism in a large cohort of Italian patients.

Authors:  Annagiusi Gargiulo; Francesco Testa; Settimio Rossi; Valentina Di Iorio; Simona Fecarotta; Teresa de Berardinis; Antonello Iovine; Adriano Magli; Sabrina Signorini; Elisa Fazzi; Maria Silvana Galantuomo; Maurizio Fossarello; Sandro Montefusco; Alfredo Ciccodicola; Alberto Neri; Claudio Macaluso; Francesca Simonelli; Enrico Maria Surace
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-14       Impact factor: 4.799

8.  Oculocutaneous albinism among schoolchildren in Harare, Zimbabwe.

Authors:  F Kagore; P M Lund
Journal:  J Med Genet       Date:  1995-11       Impact factor: 6.318

Review 9.  DNA variations in oculocutaneous albinism: an updated mutation list and current outstanding issues in molecular diagnostics.

Authors:  Dimitre R Simeonov; Xinjing Wang; Chen Wang; Yuri Sergeev; Monika Dolinska; Matthew Bower; Roxanne Fischer; David Winer; Genia Dubrovsky; Joan Z Balog; Marjan Huizing; Rachel Hart; Wadih M Zein; William A Gahl; Brian P Brooks; David R Adams
Journal:  Hum Mutat       Date:  2013-04-30       Impact factor: 4.878

10.  Hermansky-Pudlak syndrome in two African-American brothers.

Authors:  Melissa A Merideth; Lisa M Vincent; Susan E Sparks; Richard A Hess; Irini Manoli; Kevin J O'Brien; Ekaterina Tsilou; James G White; Marjan Huizing; William A Gahl
Journal:  Am J Med Genet A       Date:  2009-05       Impact factor: 2.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.